Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Response to: 'response to: irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?' by Proft et al.

Wallman JK, Mogard E, Marsal J, Andréasson K, Jöud A, Geijer M, Kristensen LE, Lindqvist E, Olofsson T.

Ann Rheum Dis. 2019 Dec 31. pii: annrheumdis-2019-216752. doi: 10.1136/annrheumdis-2019-216752. [Epub ahead of print] No abstract available.

PMID:
31892532
2.

Secukinumab efficacy on resolution of enthesitis in psoriatic arthritis: pooled analysis of two phase 3 studies.

Coates LC, Wallman JK, McGonagle D, Schett GA, McInnes IB, Mease PJ, Rasouliyan L, Quebe-Fehling E, Asquith DL, Fasth AER, Pricop L, Gaillez C.

Arthritis Res Ther. 2019 Dec 4;21(1):266. doi: 10.1186/s13075-019-2055-z.

3.

Irritable bowel syndrome symptoms in axial spondyloarthritis more common than among healthy controls: is it an overlooked comorbidity?

Wallman JK, Mogard E, Marsal J, Andréasson K, Jöud A, Geijer M, Kristensen LE, Lindqvist E, Olofsson T.

Ann Rheum Dis. 2020 Jan;79(1):159-161. doi: 10.1136/annrheumdis-2019-216134. Epub 2019 Oct 4. No abstract available.

PMID:
31585930
4.

Association of female sex and positive rheumatoid factor with low serum infliximab and anti-drug antibodies, related to treatment failure in early rheumatoid arthritis: results from the SWEFOT trial population.

Hambardzumyan K, Hermanrud C, Marits P, Vivar N, Ernestam S, Wallman JK, van Vollenhoven RF, Fogdell-Hahn A, Saevarsdottir S; SWEFOT study group.

Scand J Rheumatol. 2019 Sep;48(5):362-366. doi: 10.1080/03009742.2019.1602670. Epub 2019 Jun 27.

PMID:
31244356
5.

Considerations for Evaluating and Recommending Worker Productivity Outcome Measures: An Update from the OMERACT Worker Productivity Group.

Verstappen SMM, Lacaille D, Boonen A, Escorpizo R, Hofstetter C, Bosworth A, Leong A, Leggett S, Gignac MAM, Wallman JK, Ter Wee MM, Berghea F, Agaliotis M, Tugwell P, Beaton D.

J Rheumatol. 2019 Oct;46(10):1401-1405. doi: 10.3899/jrheum.181201. Epub 2019 Apr 1.

PMID:
30936275
6.

Serum Biomarkers for Prediction of Response to Methotrexate Monotherapy in Early Rheumatoid Arthritis: Results from the SWEFOT Trial.

Hambardzumyan K, Bolce RJ, Wallman JK, van Vollenhoven RF, Saevarsdottir S.

J Rheumatol. 2019 Jun;46(6):555-563. doi: 10.3899/jrheum.180537. Epub 2019 Feb 1.

PMID:
30709958
7.

Elevated faecal calprotectin is linked to worse disease status in axial spondyloarthritis: results from the SPARTAKUS cohort.

Olofsson T, Lindqvist E, Mogard E, Andréasson K, Marsal J, Geijer M, Kristensen LE, Wallman JK.

Rheumatology (Oxford). 2019 Jul 1;58(7):1176-1187. doi: 10.1093/rheumatology/key427.

PMID:
30649509
8.

Patient-Reported Outcomes Are More Important Than Objective Inflammatory Markers for Sick Leave in Biologics-Treated Patients With Rheumatoid Arthritis.

Olofsson T, Söderling JK, Gülfe A, Kristensen LE, Wallman JK.

Arthritis Care Res (Hoboken). 2018 Nov;70(11):1712-1716. doi: 10.1002/acr.23619.

9.

Work disability in non-radiographic axial spondyloarthritis patients before and after start of anti-TNF therapy: a population-based regional cohort study from southern Sweden.

Wallman JK, Jöud A, Olofsson T, Jacobsson LTH, Bliddal H, Kristensen LE.

Rheumatology (Oxford). 2017 May 1;56(5):716-724. doi: 10.1093/rheumatology/kew473.

PMID:
28064208
10.

A Multi-Biomarker Disease Activity Score and the Choice of Second-Line Therapy in Early Rheumatoid Arthritis After Methotrexate Failure.

Hambardzumyan K, Saevarsdottir S, Forslind K, Petersson IF, Wallman JK, Ernestam S, Bolce RJ, van Vollenhoven RF.

Arthritis Rheumatol. 2017 May;69(5):953-963. doi: 10.1002/art.40019. Epub 2017 Mar 31.

12.

Costs in Relation to Disability, Disease Activity, and Health-related Quality of Life in Rheumatoid Arthritis: Observational Data from Southern Sweden.

Wallman JK, Eriksson JK, Nilsson JÅ, Olofsson T, Kristensen LE, Neovius M, Geborek P.

J Rheumatol. 2016 Jul;43(7):1292-9. doi: 10.3899/jrheum.150617. Epub 2016 Jun 1.

PMID:
27252420
13.

Infliximab Versus Conventional Combination Treatment and Seven-Year Work Loss in Early Rheumatoid Arthritis: Results of a Randomized Swedish Trial.

Eriksson JK, Wallman JK, Miller H, Petersson IF, Ernestam S, Vivar N, van Vollenhoven RF, Neovius M.

Arthritis Care Res (Hoboken). 2016 Dec;68(12):1758-1766. doi: 10.1002/acr.22899.

14.

Association of a multibiomarker disease activity score at multiple time-points with radiographic progression in rheumatoid arthritis: results from the SWEFOT trial.

Hambardzumyan K, Bolce RJ, Saevarsdottir S, Forslind K, Wallman JK, Cruickshank SE, Sasso EH, Chernoff D, van Vollenhoven RF.

RMD Open. 2016 Mar 1;2(1):e000197. doi: 10.1136/rmdopen-2015-000197. eCollection 2016.

17.

Cranial CT of autosomal recessive osteopetrosis.

Bartynski WS, Barnes PD, Wallman JK.

AJNR Am J Neuroradiol. 1989 May-Jun;10(3):543-50.

PMID:
2501985
18.

Proton magnetic resonance studies of triethyltin-induced edema during perinatal brain development in rabbits.

Lorenzo AV, Jolesz FA, Wallman JK, Ruenzel PW.

J Neurosurg. 1989 Mar;70(3):432-40.

PMID:
2915251
19.

Bilateral lucency of the globus pallidus complicating methylmalonic acidemia.

Korf B, Wallman JK, Levy HL.

Ann Neurol. 1986 Sep;20(3):364-6.

PMID:
3767321
20.

Mapping of normal and abnormal cerebrospinal fluid flow/motion patterns using steady state free precession imaging.

Jolesz FA, Patz S, Hawkes RC, Wallman JK.

Acta Radiol Suppl. 1986;369:302-4.

PMID:
2980481
21.

Subclinical brain swelling in children during treatment of diabetic ketoacidosis.

Krane EJ, Rockoff MA, Wallman JK, Wolfsdorf JI.

N Engl J Med. 1985 May 2;312(18):1147-51.

PMID:
3920521
22.

Pressure indicating bag for monitoring intracranial pressure. Technical note.

Numoto M, Wallman JK, Donaghy RM.

J Neurosurg. 1973 Dec;39(6):784-7. No abstract available.

PMID:
4759667

Supplemental Content

Loading ...
Support Center